Showing results (151-160 of 179) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.Future Oncology (London, England)|November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summaryGrace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2015
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in OsteosarcomaAnkita Gupte, Emma K Baker, Soo-San Wan, et al.British Journal of Cancer|August 26, 2015
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancerRobert N Jorissen, Michael Christie, Dmitri Mouradov, et al.Journal for Immunotherapy of Cancer|October 17, 2023
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinomaPhilip Clingan, Rahul Ladwa, Daniel Brungs, et al.Journal for Immunotherapy of Cancer|June 17, 2020
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumorsJayesh Desai, Sanjeev Deva, Jong Seok Lee, et al.Cancer Immunology, Immunotherapy : CII|April 4, 2023
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumorsJohanna Bendell, Patricia LoRusso, Michael Overman, et al.Molecular Cancer Therapeutics|November 7, 2022
Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell DeathLaura J Jenkins, Ian Y Luk, W Douglas Fairlie, et al.Science Translational Medicine|July 8, 2016
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancerJeanne Tie, Yuxuan Wang, Cristian Tomasetti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2011
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancerJeanne Tie, Lara Lipton, Jayesh Desai, et al.Pageof 18